clinical trials

Syndicate content

Energy supplement under study for Parkinson's disease

Whether a supplement used by athletes to boost energy levels and build muscle can slow progression of Parkinson's disease is the focus of a North American study.

Get the full story...

Negative Articles about Clinical Trials Decrease Public Willingness to Participate

A University of Missouri-Columbia study has found that newspapers' front page and section stories about clinical trials are overwhelmingly negative and that exposure to these stories may decrease people's willingness to participate in medical trials.

Get the full story...

Novel clinical trial testing adult stem cells for heart damage repair

The University of Wisconsin School of Medicine and Public Health is among the first medical centers in the country taking part in a novel clinical trial investigating if a subject's own stem cells can treat a form of severe coronary artery disease.

Read the full story

Taking wraps off drug safety data from clinical trials

For years, pharmaceutical companies have sought to restrict public access to drug safety data collected in clinical trials on the basis that it is proprietary information, arguing that competitors could use that information in the development of their own products. However, a number of recent cases of drugs found to have dangerous side effects after coming to market, such as the anti-inflammatory drug rofecoxib (Vioxx), have raised concerns about safety data being treated as confidential.

Read the full story

First large-scale HIV vaccine trial in South Africa opens

A large-scale clinical trial of a candidate HIV vaccine-which previously showed promise in smaller studies in the United States and elsewhere-has now opened in South Africa. The study plans to enroll up to 3,000 HIV-negative men and women, making it the largest African HIV vaccine trial to date.

Read the full story

Conflicting attitudes hinder participation in clinical trials

Women have conflicting attitudes about participating in clinical trials because of uncertainties about trusting the experimenters, fear of the trial itself, and hope that the research will result in medical progress, according to a new study at Wake Forest University School of Medicine.

Read the full story